On April 11, the world celebrated 200 years of Parkinson’s disease research. On this occasion, an exhibition retracing the medical history was hosted at the Luxembourg City train station and researchers from NCER-PD got to answer the questions of interested visitors.
NCER-PD stands for the National Centre of Excellence in Research on Parkinson’s Disease. It represents a joint effort between 4 partners in Luxembourg (IBBL, LIH, CHL, LCSB) that have set themselves the aim of finding new ways for an earlier diagnosis and better treatment for Parkinson’s disease.
In order to decipher the causes of the disease and the way it develops, Parkinson’s disease patients as well as healthy volunteers are invited to take part in the project. Active participation is important for the success of the Luxembourgish study and advancing our understanding of the disease, which in many ways is still a mystery.
In 2016, just over 380 patients and healthy donors were recruited. Their biological samples, such as blood, urine and saliva, as well as their associated clinical data were handled with the greatest care by the biobank, which also set up quality control tests to maximise donors’ contribution and ensure that researchers receive samples of uniform quality that are fit for their downstream research purpose.
Should you be interested in taking part in the study or in learning more, please visit this website.